Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP Trial.
Patel P, Dreibe S, Attard G, Cole A, Diez P, Frew J, Guevara J, Levine D, McDonald F, Mullassery V, Murray J, Parker C, Palaniappan N, Pathmanathan A, Reid A, Suh YE, Syndikus I, Tirona A, Tran A, Tunariu N, van As NJ, Wylie J, Tree AC. Patel P, et al. Among authors: tree ac. Int J Radiat Oncol Biol Phys. 2025 Mar 9:S0360-3016(25)00225-1. doi: 10.1016/j.ijrobp.2025.02.046. Online ahead of print. Int J Radiat Oncol Biol Phys. 2025. PMID: 40068778 Free article.
HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.
Cooper S, Westley RL, Biscombe K, Dunlop A, Mitchell A, Oelfke U, Nill S, Manning G, Burnett S, Murray J, Wilkins A, Tunariu N, Price D, Adkins A, Pathmanathan A, Bucinskaite G, Hafeez S, Parker C, Ratnakumaran R, Verkooijen H, Alexander S, Herbert T, Hall E, Tree AC. Cooper S, et al. Among authors: tree ac. Int J Radiat Oncol Biol Phys. 2025 Nov 1;123(3):773-782. doi: 10.1016/j.ijrobp.2025.05.008. Epub 2025 May 20. Int J Radiat Oncol Biol Phys. 2025. PMID: 40403882 Free article. Clinical Trial.
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Tree AC, Hinder V, Chan A, Tolan S, Ostler P, van der Voet H, Kancherla K, Loblaw A, Naismith O, Jain S, Martin A, Price D, Brand D, Chu W, Duffton A, Kelly P, O'Neill B, Staffurth J, Sasso G, Pugh J, Manning G, Brown S, Burnett S, Griffin C, Hall E, van As N; PACE Investigators. Tree AC, et al. Lancet Oncol. 2025 Jul;26(7):936-947. doi: 10.1016/S1470-2045(25)00205-0. Epub 2025 Jun 12. Lancet Oncol. 2025. PMID: 40517778 Free PMC article. Clinical Trial.
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Gillessen S, Murphy L, James ND, Sachdeva A, El-Taji O, Abdel-Aty H, Adler AI, Amos C, Attard G, Varughese M, Gale J, Brown S, Srihari N, Birtle AJ, Brown M, Chan K, Chowdhury S, Cross W, Dearnaley DP, Din O, Dutey-Magni P, Gilbert DC, Gilson C, Gray S, Grist E, Hofmann U, Hudson AM, Jain Y, Jeyasangar G, Jones R, Kayani M, Langley RE, Malik Z, Mason MD, Matheson D, McAlpine C, Macnair A, Millman R, Murphy C, Padden-Modi M, Parikh O, Parker C, Rush H, Russell M, Srinivasan R, Sundar S, Tanguay JS, Turco F, Williams P, Sydes MR, Parmar MKB, Brown LC, Clarke NW; STAMPEDE investigators. Gillessen S, et al. Lancet Oncol. 2025 Aug;26(8):1018-1030. doi: 10.1016/S1470-2045(25)00231-1. Epub 2025 Jul 7. Lancet Oncol. 2025. PMID: 40639383 Free PMC article. Clinical Trial.
137 results